196 related articles for article (PubMed ID: 33262813)
1. Investigation of the relationship between chronic montelukast treatment, asthma and depression-like behavior in mice.
Tel BC; Telli G; Onder S; Nemutlu E; Bozkurt TE
Exp Ther Med; 2021 Jan; 21(1):27. PubMed ID: 33262813
[TBL] [Abstract][Full Text] [Related]
2. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
3. lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma.
Xu Z; Meng L; Xie Y; Guo W
Braz J Med Biol Res; 2020; 53(7):e9271. PubMed ID: 32520202
[TBL] [Abstract][Full Text] [Related]
4. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
6. [Effect of montelukast sodium intervention on airway remodeling and percentage of Th17 cells/CD4+CD25+ regulatory T cells in asthmatic mice].
Li L; Lou CY; Li M; Zhang JB; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Nov; 18(11):1174-1180. PubMed ID: 27817787
[TBL] [Abstract][Full Text] [Related]
7. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
8. Montelukast: data from clinical trials in the management of asthma.
Blake KV
Ann Pharmacother; 1999 Dec; 33(12):1299-314. PubMed ID: 10630831
[TBL] [Abstract][Full Text] [Related]
9. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
10. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
11. The effects of montelukast on eosinophilic gastroenteritis in a mouse model.
Wan D; Liu X; Li G
Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):292-5. PubMed ID: 23240855
[TBL] [Abstract][Full Text] [Related]
12. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade.
Henderson WR; Chiang GK; Tien YT; Chi EY
Am J Respir Crit Care Med; 2006 Apr; 173(7):718-28. PubMed ID: 16387808
[TBL] [Abstract][Full Text] [Related]
13. Montelukast reverses airway remodeling in actively sensitized young mice.
Debelleix S; Siao-Him Fa V; Begueret H; Berger P; Kamaev A; Ousova O; Marthan R; Fayon M
Pediatr Pulmonol; 2018 Jun; 53(6):701-709. PubMed ID: 29493871
[TBL] [Abstract][Full Text] [Related]
14. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice.
Mao H; Yin KS; Wang ZL; Li FY; Zhang XL; Liu CT; Lei S
Chin Med J (Engl); 2004 Apr; 117(4):592-7. PubMed ID: 15109455
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs.
Leick-Maldonado EA; Kay FU; Leonhardt MC; Kasahara DI; Prado CM; Fernandes FT; Martins MA; Tibério IF
Clin Exp Allergy; 2004 Jan; 34(1):145-52. PubMed ID: 14720275
[TBL] [Abstract][Full Text] [Related]
17. [Effect of montelukast on the expression of neurokinin-1 receptor in young asthmatic rats with airway remodeling].
Wei B; Shang YX; Li M; Zhang H
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):298-301. PubMed ID: 23607955
[TBL] [Abstract][Full Text] [Related]
18. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
[TBL] [Abstract][Full Text] [Related]
19. Validity Assessment of 5 Day Repeated Forced-Swim Stress to Model Human Depression in Young-Adult C57BL/6J and BALB/cJ Mice.
Mul JD; Zheng J; Goodyear LJ
eNeuro; 2016; 3(6):. PubMed ID: 28058270
[TBL] [Abstract][Full Text] [Related]
20. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
